Defining Antibiotic Stewardship & HEDIS Measures
Expires June 30, 2025
The training will review measures and provide a framework for health plans to use their claims, pharmacy, and clinical data to identify, prioritize and monitor antibiotic stewardship efforts.
Bundle and save! Click Here for the The Medical Home Subscription plan pricing.
About this On Demand Training
Defining Antibiotic Stewardship and Reviewing Associated HEDIS® Measures
Inappropriate antibiotic use is a long-standing public health issue. An estimated 30% of outpatient antibiotic prescriptions are inappropriate. Antibiotic stewardship aims to improve how antibiotics are prescribed by clinicians and used by patients. HEDIS® includes three measures that assess antibiotic prescribing for bronchitis/bronchiolitis, upper respiratory infection and pharyngitis - three conditions that drive significant levels of inappropriate prescribing in the U.S. These measures provide a framework for health plans to use their claims, pharmacy, and clinical data to identify, prioritize and monitor antibiotic stewardship efforts.
Subject matter experts will provide an overview and updates on:
- Antibiotic stewardship
- Three HEDIS antibiotic measures
- HEDIS antibiotic measure performance
What You Will Learn
At the conclusion of the course, learners will be able to:
- Define the critical importance of antibiotic use and stewardship.
- Understand the importance of three HEDIS antibiotic measures, including how these measures have changed over time.
- Describe health plan performance from MY 2020.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Who Should Attend
- Federal and state government agencies
- Health care decision makers
- Health care professionals
- Health centers/health practices
- Health plans
- Health systems
- Population health organizations
Sepheen Byron, DRPH, MHS
Sepheen Byron is Assistant Vice President, Performance Measurement, at the National Committee for Quality Assurance (NCQA). She oversees measure development and use of HEDIS and other national evaluation programs and has developed measures used by NCQA for Accreditation, benchmarking and ratings. She also led measure development for Medicaid and CHIP enrollees as part of NCQA’s AHRQ-CMS Pediatric Quality Measures Program Center of Excellence. Ms. Byron is the subject matter expert for measures in the area of antibiotic stewardship, and recently led a project to broaden HEDIS antibiotic measures to additional populations.
Prior to NCQA, Ms. Byron was an Analyst in the Center for Outcomes and Evidence at the Agency for Healthcare Research and Quality, where she assessed the effectiveness of health services.
Ms. Byron has a BA from the University of Virginia, an MHS from the Johns Hopkins University Bloomberg School of Public Health, and a DrPH from the Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
Nancy McGee, MS, MBA
Nancy A. McGee is an Assistant Director in the Research and Analysis Department at the National Committee for Quality Assurance (NCQA). She is responsible for the development and maintenance of HEDIS measures primarily addressing geriatric health care. She has also worked on research efforts focused on person-driven outcomes for individuals with serious illness, multiple chronic conditions and disabilities.
Prior to joining NCQA, Ms. McGee worked in employee benefits, including as a benefits manager for a national employee organization; as a Health and Benefits Consultant for Mercer; and as a Project Manager implementing benefits administration systems for ADP and Ceridian.
Ms. McGee has an MS in Gerontology from the University of Utah School of Nursing and an MBA from the David Eccles School of Business at the University of Utah.
In support of improving patient care, the National Committee for Quality Assurance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide Interprofessional Continuing Education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
This educational activity is approved for a maximum of 1.0 AMA PRA Category 1 Credit™, and ACPE.
This educational activity is approved for 1.0 nursing contact hours.*
The assigned universal program number: JA0004597-0000-22-030-H04-P. Upon successful completion of this program (attending the full session and completing a program evaluation), participants will access CPE Monitor on the ACPE website to locate and track their CPE statement of credit.
This live course grants 1.0 Continuing Education Unit (CEU) points for PCMH Certified Content Experts.
* Please note – You must attend the entire program to be eligible for total number of contact hours.
NABP Credit Reporting
If you are a pharmacist completing a course offering CPE credits, please notify NCQA through ncqa.org within 14 calendar days that you have completed a CPE course. You must provide the title of the course, your NABP identification number and your DOB (month/date) within the notification to NCQA. We also recommend you update your education.ncqa.org profile with your NABP identification number.
Disclosure of Relevant Financial Relationships
The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations.
For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution. For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.
Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist with the following companies/organizations:
Sepheen Byron: Dr. Byron received funding from the Centers for Disease Control and Prevention (contract no. 75D30120C08243) to develop the measure related to antibiotic utilization.
Additional Planning Committee Members:
Ashley Turner: None
Nancy McGee: None
This program was developed in part by NCQA staff.
Support for this project was provided by The Pew Charitable Trusts.
“The views expressed are those of the author(s) and do not necessarily reflect the views of The Pew Charitable Trusts”.
Here is the course outline:
The following certificates are awarded when the course is completed:
|Certificate of Attendance